<VariationArchive VariationID="1707706" VariationName="NM_000018.4(ACADVL):c.103_112dup (p.Arg38fs)" VariationType="Duplication" Accession="VCV001707706" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-10-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1706005" VariationID="1707706">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
        <Gene Symbol="LOC130060113" FullName="ATAC-STARR-seq lymphoblastoid silent region 8088" GeneID="130060113" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7220062" stop="7220271" display_start="7220062" display_stop="7220271" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.103_112dup (p.Arg38fs)</Name>
      <CanonicalSPDI>NC_000017.11:7220154:GCCCGGCCCTGCCCGGC:GCCCGGCCCTGCCCGGCCCTGCCCGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7220154" stop="7220155" display_start="7220154" display_stop="7220155" variantLength="10" positionVCF="7220154" referenceAlleleVCF="G" alternateAlleleVCF="GGCCCGGCCCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7123473" stop="7123474" display_start="7123473" display_stop="7123474" variantLength="10" positionVCF="7123473" referenceAlleleVCF="G" alternateAlleleVCF="GGCCCGGCCCT" />
      </Location>
      <OtherNameList>
        <Name>NM_000018.4:c.103_112dup</Name>
      </OtherNameList>
      <ProteinChange>R38fs</ProteinChange>
      <ProteinChange>R61fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7123481_7123490dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7123481_7123490dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7220162_7220171dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7220162_7220171dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.5329_5338dup">
            <Expression>NG_007975.1:g.5329_5338dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.3" sequenceAccession="NG_008391" sequenceVersion="3" change="g.4886_4895dup">
            <Expression>NG_008391.3:g.4886_4895dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.103_112dup" MANESelect="true">
            <Expression>NM_000018.4:c.103_112dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000009.1" sequenceAccession="NP_000009" sequenceVersion="1" change="p.Arg38fs">
            <Expression>NP_000009.1:p.Arg38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.103_112dup">
            <Expression>NM_001033859.3:c.103_112dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001029031.1" sequenceAccession="NP_001029031" sequenceVersion="1" change="p.Arg38fs">
            <Expression>NP_001029031.1:p.Arg38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.172_181dup">
            <Expression>NM_001270447.2:c.172_181dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257376.1" sequenceAccession="NP_001257376" sequenceVersion="1" change="p.Arg61fs">
            <Expression>NP_001257376.1:p.Arg61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.-126_-117dup">
            <Expression>NM_001270448.2:c.-126_-117dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.103_112dup10" MANESelect="true">
            <Expression>NM_000018.4:c.103_112dup10</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.103_112dup (p.Arg38fs) AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV002286685" Version="3">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-03-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-10-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11590124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29519241</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29768383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9973285</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fd08bf0b-f055-489a-85c5-8aa442eac57e</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5037550" SubmissionDate="2023-04-11" DateLastUpdated="2023-04-23" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="fd08bf0b-f055-489a-85c5-8aa442eac57e" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002576752" DateUpdated="2023-04-23" DateCreated="2022-10-08" Type="SCV" Version="2" SubmitterName="ClinGen ACADVL Variant Curation Expert Panel, ClinGen" OrgID="508473" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-08">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fd08bf0b-f055-489a-85c5-8aa442eac57e</URL>
          </Citation>
          <Comment>The NM_000018.4: c.103_112dup10 (p.Arg38ProfsTer24) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 2/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). This variant has been detected in at least 2 individuals with very long chain acyl CoA dehydrogenase (VLCAD) deficiency identified by increased C14:1 levels by newborn screen and one of these individuals had an acylcarnitine analysis consistent with VLCAD deficiency (PP4_moderate; PMID: 29519241, 29768383). One of these individuals was homozygous for the variant (PM3_supporting; PMID: 29768383). This variant is absent from gnomAD v2.1.1 (PM2_supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PP4_moderate, PM3_supporting, PM2_supporting (VCEP specifications v2.0, approved on 09/16/2021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen acadvl acmg specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/iz6xgwit/clingen_acadvl_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000018.4:c.103_112dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7220162_7220171dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ACADVL EP ClinVar Submission 2</SubmissionName>
          <SubmissionName>ACADVL updated April 2023 submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8328405" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="5897666|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004538948" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11590124</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29519241</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29768383</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg38Profs*24) in the ACADVL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADVL are known to be pathogenic (PMID: 9973285, 11590124). This premature translational stop signal has been observed in individual(s) with VLCAD deficiency (PMID: 29519241, 29768383). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1707706).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7123473_7123474insGCCCGGCCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8328405" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5037550" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008723" MappingRef="MONDO">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

